Events

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce its attendance at the Genesis 2024 Conference, being held today, 4th December 2024, in London, UK.    Genesis, delivered by One Nucleus, is a premier event for the life sciences sector bringing together global leaders in drug development, investment, and innovation....

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce its attendance at the upcoming PKUK Technical Meeting. This event, which brings together experts across the PKPD and quantitative pharmacology field, will take place on 27-29 November 2024 at Coppid Beech Hotel, Bracknell, UK and serves as a platform to explore...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is proud to have attended the 36th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium (ENA2024) in Barcelona, Spain on the 23rd – 25th of October 2024. ENA is an international drug development and translational research meeting, focusing on preclinical and phase I studies...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, proudly attended the 30th annual BIO-Europe conference held in Stockholm, Sweden, from 4th to 6th November 2024. BIO-Europe is Europe's premier partnering event, bringing together over 5,700 attendees from more than 3,000 companies to drive innovation in the biotechnology and pharmaceutical sectors.    Representing Physiomics...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it is attending BioForward 2024, OBN’s  'Roadmap for Growth' Life Sciences event, in Oxford on 24th of September 2024. The event attended by leaders of R&D companies across all therapeutic areas aims to create connections within industry that...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it is attending BIO 2024 in San Diego, USA, on the 3rd – 6th of June 2024.   The BIO International Convention is the largest biotechnology event of the year, with >20,000 industry leaders attending from across the globe. Physiomics’...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it is attending Oxford Global’s Immuno 2024 Event in London on 25th and 26th of April 2024.   Physiomics’ Head of Business Development, Hayley Close will be attending the event which brings together over 400 experts in the field of...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it is attending BioTrinity 2024, OBN’s leading life sciences conference, in London on 23rd and 24th of April 2024.   Physiomics’ Head of Business Development, Hayley Close will be attending the event which aims to catalyse growth in the life...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it is attending the 14th Annual World ADC Event in London on 13th and 14th of March 2024.   Physiomics’ CEO, Dr Pete Sargent and Head of Business Development, Hayley Close will be attending the event which is Europe’s definitive...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling company supporting oncology drug development, is pleased to announce that it is attending Europe’s Flagship Partnering Event for the Life Sciences Industry, BioEurope 2023 in Munich, Germany on November 6-8th.   Physiomics’ Chief Operating Officer, Dr Pete Sargent and Head of Business Development, Hayley Close will be attending the event. The aim is to engage with leaders from across...

Read More